- Home
- ORC vs CVAC Comparison
ORC vs CVAC Comparison
Compare ORC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- CVAC
- Stock Information
- Founded
- ORC 2010
- CVAC 2000
- Country
- ORC United States
- CVAC Germany
- Employees
- ORC N/A
- CVAC N/A
- Industry
- ORC Real Estate Investment Trusts
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- ORC Real Estate
- CVAC Health Care
- Exchange
- ORC Nasdaq
- CVAC Nasdaq
- Market Cap
- ORC 611.8M
- CVAC 637.1M
- IPO Year
- ORC 2013
- CVAC 2020
- Fundamental
- Price
- ORC $8.04
- CVAC $2.86
- Analyst Decision
- ORC Buy
- CVAC Hold
- Analyst Count
- ORC 2
- CVAC 3
- Target Price
- ORC $9.50
- CVAC $10.00
- AVG Volume (30 Days)
- ORC 1.6M
- CVAC 523.1K
- Earning Date
- ORC 01-30-2025
- CVAC 11-12-2024
- Dividend Yield
- ORC 18.02%
- CVAC N/A
- EPS Growth
- ORC N/A
- CVAC N/A
- EPS
- ORC 1.01
- CVAC N/A
- Revenue
- ORC $75,695,000.00
- CVAC $70,565,734.00
- Revenue This Year
- ORC N/A
- CVAC $738.59
- Revenue Next Year
- ORC N/A
- CVAC N/A
- P/E Ratio
- ORC $7.91
- CVAC N/A
- Revenue Growth
- ORC N/A
- CVAC 75.11
- 52 Week Low
- ORC $7.41
- CVAC $2.22
- 52 Week High
- ORC $9.08
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- ORC 56.84
- CVAC 46.81
- Support Level
- ORC $8.01
- CVAC $2.85
- Resistance Level
- ORC $8.21
- CVAC $3.56
- Average True Range (ATR)
- ORC 0.12
- CVAC 0.17
- MACD
- ORC 0.01
- CVAC -0.01
- Stochastic Oscillator
- ORC 64.53
- CVAC 14.56
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.